These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34960185)

  • 1. Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination.
    Dennehy KM; Löll E; Dhillon C; Classen JM; Warm TD; Schuierer L; Hyhlik-Dürr A; Römmele C; Gosslau Y; Kling E; Hoffmann R
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
    Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study.
    Hvidt AK; Guo H; Andersen R; Lende SSF; Vibholm LK; Søgaard OS; Schleimann MH; Russell V; Cheung AM; Paramithiotis E; Olesen R; Tolstrup M
    BMC Immunol; 2023 Nov; 24(1):45. PubMed ID: 37974069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.
    Galeota E; Bevilacqua V; Gobbini A; Gruarin P; Bombaci M; Pesce E; Favalli A; Lombardi A; Vincenti F; Ongaro J; Fabbris T; Curti S; Martinovic M; Toccafondi M; Lorenzo M; Critelli A; Clemente F; Crosti M; Sarnicola ML; Martinelli M; La Sala L; Espadas A; Donnici L; Borghi MO; De Feo T; De Francesco R; Prati D; Meroni PL; Notarbartolo S; Geginat J; Gori A; Bandera A; Abrignani S; Grifantini R
    Clin Immunol; 2024 Apr; 261():110164. PubMed ID: 38417765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.
    Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G
    Front Immunol; 2021; 12():778679. PubMed ID: 34868051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
    Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
    Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    Qin K; Honjo K; Sherrill-Mix S; Liu W; Stoltz RM; Oman AK; Hall LA; Li R; Sterrett S; Frederick ER; Lancaster JR; Narkhede M; Mehta A; Ogunsile FJ; Patel RB; Ketas TJ; Cruz Portillo VM; Cupo A; Larimer BM; Bansal A; Goepfert PA; Hahn BH; Davis RS
    PLoS Med; 2023 Jun; 20(6):e1004157. PubMed ID: 37384638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine.
    Wang C; Yang S; Duan L; Du X; Tao J; Wang Y; Yang J; Lv Y; Li J; Zhang C; Wen J; Zhu Y; Chang L; Wang H; Wang Q; Zhao W
    Virol J; 2022 Dec; 19(1):223. PubMed ID: 36550578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
    Mazzoni A; Vanni A; Spinicci M; Lamacchia G; Kiros ST; Rocca A; Capone M; Di Lauria N; Salvati L; Carnasciali A; Mantengoli E; Farahvachi P; Zammarchi L; Lagi F; Colao MG; Liotta F; Cosmi L; Maggi L; Bartoloni A; Rossolini GM; Annunziato F
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35139036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominantly defective CD8
    Taus E; Shino MY; Ibarrondo FJ; Hausner MA; Hofmann C; Yang OO
    J Transl Med; 2023 Jun; 21(1):374. PubMed ID: 37291575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.
    Yang LT; Peng H; Zhu ZL; Li G; Huang ZT; Zhao ZX; Koup RA; Bailer RT; Wu CY
    Clin Immunol; 2006 Aug; 120(2):171-8. PubMed ID: 16781892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
    Zonozi R; Walters LC; Shulkin A; Naranbhai V; Nithagon P; Sauvage G; Kaeske C; Cosgrove K; Nathan A; Tano-Menka R; Gayton AC; Getz MA; Senjobe F; Worrall D; Iafrate AJ; Fromson C; Montesi SB; Rao DA; Sparks JA; Wallace ZS; Farmer JR; Walker BD; Charles RC; Laliberte K; Niles JL; Gaiha GD
    Sci Transl Med; 2023 Nov; 15(724):eadh4529. PubMed ID: 38019932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype.
    Guerrera G; Picozza M; D'Orso S; Placido R; Pirronello M; Verdiani A; Termine A; Fabrizio C; Giannessi F; Sambucci M; Balice MP; Caltagirone C; Salvia A; Rossini A; Battistini L; Borsellino G
    Sci Immunol; 2021 Dec; 6(66):eabl5344. PubMed ID: 34726470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.
    Zhang R; Shin BH; Gadsden TM; Petrosyan A; Vo A; Ammerman N; Sethi S; Huang E; Peng A; Najjar R; Atienza J; Kim I; Jordan SC
    Transpl Infect Dis; 2022 Apr; 24(2):e13813. PubMed ID: 35202497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated CD21
    Bergman P; Wullimann D; Gao Y; Wahren Borgström E; Norlin AC; Lind Enoksson S; Aleman S; Ljunggren HG; Buggert M; Smith CIE
    J Clin Immunol; 2022 May; 42(4):716-727. PubMed ID: 35290571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
    Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
    Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.